| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP & Chief Compliance Officer
1 company
Katrina J Church is SVP & Chief Compliance Officer at BVS. Katrina J Church's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $702K at current prices.
Our model assigns Katrina J Church a middling insider score of 52/100, based on 14 past trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of -15.0%.
The BVS filings lean toward selling, a net 19,707 shares.
Katrina J Church has 27 Form 4 filings on record from February 2021 to April 2026, all as SVP & Chief Compliance Officer at Bioventus (BVS), 2021–2026.
The 44 reported transactions were 14 open-market sales, 13 option exercises, 12 option or other derivative awards and 4 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $33K and 12 sales worth about $144K.
The only open-market purchase was 2,500 shares of BVS at an average $13.00 on February 11, 2021, about $33K.
The largest open-market sale was 8,759 shares of BVS at an average $5.84 on June 17, 2024, about $51K. Twelve months later BVS was up 7%.
8 of the 10 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 2 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 1,283 | $7.57 | $9,712.31 | -2.3% | -1.2% | +21.1% | |
| Mar 17, 2025 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 1,018 | $9.75 | $9,925.50 | -1.9% | -32.7% | -8.3% | |
| Feb 18, 2025 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 1,537 | $10.19 | $15,662.03 | -3.0% | -33.3% | -18.3% | |
| Dec 23, 2024 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 2,535 | $10.53 | $26,693.55 | -5.1% | -8.7% | -29.3% | |
| Jun 21, 2024 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 2,559 | $5.57 | $14,253.63 | -5.8% | +104.4% | +15.5% | |
| Jun 17, 2024 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 8,759 | $5.84 | $51,152.56 | -19.9% | +86.2% | +6.9% | |
| Apr 11, 2024 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 1,325 | $4.75 | $6,293.75 | -7.2% | +22.5% | +55.5% | |
| Mar 15, 2024 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell | 1,217 | $5.46 | $6,644.82 | -8.0% | +20.0% | +76.3% | |
| Jul 3, 2023 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell | 394 | $2.83 | $1,115.02 | -3.2% | +13.6% | +106.4% | |
| Apr 3, 2023 | BVS Bioventus Inc. | SVP & Chief Compliance Officer | Sell10b5-1 | 117 | $1.07 | $125.19 | -1.1% | +147.8% | +346.0% |